Lab Results – OROS Research (Replica)

Certificates of Analysis

Browse certificates by product, lot, and batch.

Quality Assurance Program

9-Point Batch Verification

Every OROS batch is submitted to independent, ISO/IEC 17025-accredited laboratories for testing. Panels run up to 9 points of verification — the exact tests performed vary by product, dosage form, and batch — and can include identity, purity, net content, multi-vial variance, endotoxins, heavy metals, microbial contamination, residual solvents, and adulterant screening. The published report for each lot shows exactly which tests were performed.

Independent 3rd Party Testing ISO/IEC 17025 Accredited Lab Verifiable Lab Reports Published
July 2026 Update: Adulterant Screening
As of July 29th, 2026, every newly manufactured OROS batch undergoes USP <2251> testing (Screening for Undeclared Drugs and Drug Analogues) for undeclared drugs and drug analogues, confirming the material is free of illicit contaminants. OROS maintains a controlled supply chain, and all raw active pharmaceutical ingredients are tested before formulation. This additional finished-batch screening provides another layer of quality assurance, transparency, and confidence in the integrity of our research products. The applicable screening results will be included within each batch’s COA record.
June 2026 Update: Residual Solvent Testing
OROS has expanded its batch-level quality-control program to include USP <467> residual-solvent analysis for all newly manufactured batches. The testing panel screens for trace levels of: Acetonitrile, Methanol, N,N-Dimethylformamide (DMF), Dichloromethane, Diethyl ether, Isopropanol, Ethanol, Tetrahydrofuran (THF), and Trifluoroacetic acid (TFA). Because this testing was introduced in June 2026, batches manufactured before that date do not include residual-solvent analysis within their testing panels.
April 2026 Update: ISO Accredited Testing
All new batches are validated through an ISO 17025-accredited laboratory, supporting method accuracy, reproducibility, and compliance with recognized analytical standards. Residual solvent analysis will be incorporated next as part of the continued expansion of our quality control program.

OROS Quality Standards

≥ 98% Purity, Guaranteed

Purity is confirmed by HPLC at an independent laboratory before a batch is released. If a result comes back below specification, the batch is rejected and never sold — and the report stays on file.

Contaminant Testing, Every Batch

Heavy metals (USP <233>), microbials (USP <61>/<62>), endotoxins (USP <85>), and adulterant screening (USP <2251>) are tested on every batch before release.

USA Formulated

100% of OROS batches are formulated, filled, and finished in U.S. facilities under documented chain-of-custody controls, from raw material intake through final release.

COA PDFs: Expand a product, then a lot, to view or download the published laboratory PDF for that batch. All 232 reports are linked from the live OROS COA library.

FOR RESEARCH USE ONLY. Products listed are intended exclusively for in-vitro laboratory research. Not for human consumption, therapeutic, diagnostic, veterinary, or clinical use.